Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

Illumina has a long history of driving advancements in genomics, providing the tools and technologies that have ...

19, 2024 /PRNewswire/ -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate ...

The FDA grants orphan drug and rare pediatric disease designations to LBPH's lead pipeline drug for the treatment of Dravet Syndrome. Data from a late-stage study shows that co-administering GSK's ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

San Diego-headquartered Illumina, a leader in DNA sequencing and array-based technologies, said it will establish a Global Capability Center (GCC) in Bengaluru as part of its plans to expand the ...

No description, website, or topics provided.

19, 2024 /PRNewswire/ — Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

Illumina Inc, a major biotech firm in DNA sequencing and array-based technologies, on Friday announced the setting up of a Global Capability Center in Bengaluru. The centre would be an investment to ...